Frauke Förger

Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study

Xavier Mariette, Frauke Förger, Bincy Abraham et al. · Annals of the Rheumatic Diseases · 2017 · 393 citations · Full text

Medicine, Obstetrics, Pharmacology +14

Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis

I Vallbracht, Johannes Rieber, Martin Oppermann et al. · Annals of the Rheumatic Diseases · 2004 · 232 citations

Life Sciences, Immunology, Internal Medicine +17

Pregnancy Outcomes After Exposure to Certolizumab Pegol

Megan E. B. Clowse, Angela E. Scheuerle, Christina Chambers et al. · Arthritis & Rheumatology · 2018 · 182 citations · Full text

Medicine, Obstetrics, Pharmacology +14

Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study

Megan E. B. Clowse, Frauke Förger, Caroline Hwang et al. · Annals of the Rheumatic Diseases · 2017 · 174 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis

Frauke Förger, Martin Oppermann, H. Becker et al. · Lupus · 2004 · 141 citations

Life Sciences, Immunology, Nephrology +17